CUSIP: 869367102
Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
84,733,230
-
Total 13F shares
-
63,167,394
-
Share change
-
+9,772,075
-
Total reported value
-
$185,075,042
-
Put/Call ratio
-
13800%
-
Price per share
-
$2.93
-
Number of holders
-
119
-
Value change
-
+$25,139,079
-
Number of buys
-
77
-
Number of sells
-
46
Quarterly Holders Quick Answers
What is CUSIP 869367102?
CUSIP 869367102 identifies STRO - Sutro Biopharma, Inc. - Common Stock, $0.001 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2024
-
Previous quarter:
Q1 2024
Recent filing periods for CUSIP 869367102:
Institutional Holders of Sutro Biopharma, Inc. - Common Stock, $0.001 par value (STRO) as of Q2 2024
As of 30 Jun 2024,
Sutro Biopharma, Inc. - Common Stock, $0.001 par value (STRO) was held by
119 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
63,167,394 shares.
The largest 10 holders included
SUVRETTA CAPITAL MANAGEMENT, LLC, BlackRock Inc., Point72 Asset Management, L.P., MILLENNIUM MANAGEMENT LLC, VANGUARD GROUP INC, MPM BIOIMPACT LLC, Samsara BioCapital, LLC, Kynam Capital Management, LP, ADAGE CAPITAL PARTNERS GP, L.L.C., and BAILLIE GIFFORD & CO.
This page lists
119
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.